Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

25,000-Signature Goal Set For Petition Asking President-Elect Trump To Stop DEA's War On Kratom

January 22nd Deadline Looms: 8,000 Speak Up at www.PetitionTrumpForKratom.Org in 1st 2 Weeks to Stop "Regulatory Overkill" on Coffee-Like Herb No Worse Than Nutmeg.


News provided by

American Kratom Association

Jan 04, 2017, 11:22 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, Jan. 4, 2017 /PRNewswire-USNewswire/ -- Less than three weeks remain for supporters of kratom to sign the petition at www.PetitionTrumpForKratom.com urging President-elect Donald Trump to either halt the DEA/FDA push to criminalize kratom or to reverse any 11th hour ban that might be imposed in the waning days of the Obama Administration. A target of 25,000 signatures was announced today by the American Kratom Association (AKA), which launched the online petition on Monday, December 19th.

In the first two weeks since its launch of December 19th, the PetitionTrumpforKratom.org Web site has attracted nearly 8,000 petition signers. In late November, AKA released a report by one of the world's leading addiction experts who concluded that kratom has as low or even lower potential for abuse and dependence as nutmeg and St. John's Wort.

AKA is focused intently on getting as many people as possible who have benefited from kratom to share their opposition to any classification by the DEA of the coffee-like herb as a Schedule I drug. The official deadline for signers to add their names to the petition is 11:59 p.m. EST on January 22, 2017.  The list of those signing www.PetitionTrumpForKratom.org will be presented to President-elect Trump in his first full business day in office: Monday, January 23, 2017.

American Kratom Association Director Susan Ash said: "We need a strong message sent from the kratom community to the new White House that the attack on kratom producers and consumers must end.  There is no room in an Administration committed to limited government and allowing responsible adults to live free lives for the DEA's regulatory overkill response to kratom. We urge everyone who wants to keep kratom legal to go to www.PetitionTrumpForKratom.org and sign their name."

The petition at www.PetitionTrumpForKratom.org reads in part:

"President-elect Trump:

Your promise to end excessive government regulations and restore the limited role of government in the lives of Americans is the reason that we are appealing to you today.

The three-five million Americans who choose to use the natural herb kratom to maintain their well-being desperately need your help.  We are concerned that the Drug Enforcement Administration may soon choose to curb access to this herb.  If such an 'eleventh hour' step is taken during the waning days of the Obama Administration, we ask that you reverse it upon taking office.  If the DEA has not acted by January 21st, we ask that you put an end to regulatory proceedings targeting kratom.

The DEA and the U.S. Food and Drug Administration have openly declared war on kratom consumers, and these agencies are blatantly abusing their powers to criminalize both those who produce and sell kratom products, and those who purchase and consume them.  These federal regulators are doing all they can to deny American consumers their freedom to make individual choices on the safe products they want to use to maintain their health and well-being.

Despite credible evidence proving kratom is no more addictive than a cup of coffee, and its use presents no threat to the public health, the DEA and the FDA are continuing their efforts to classify kratom as a dangerous drug – with the same classification as heroin or cocaine.

Who are we?

We are veterans … and lawyers ... and factory workers … and school teachers … and health care professionals.  We are mothers and fathers … and grandparents and senior citizens. 

We are the real face of America.  Our choice to consume kratom does not make us "drug abusers" any more than drinking a cup of coffee would …" 

The American Kratom Association is proud to be playing an instrumental role in helping to coordinate the broad-based national opposition to the DEA's attempt to effectively ban kratom.  In addition to creating www.PetitionTrumpForKratom.org, AKA also:

  • Led the charge when the DEA opened a public comment period running through December 1, 2016.  Of the more than 23,000 comments submitted before the deadline closed, the KratomComments.org Web site created by AKA was responsible for 16,379 comments – roughly 71 percent of total comments received at Regulations.gov. (The campaign Web site is now inactive.)
  • Issued on November 30, 2016 a long-awaited analysis by Dr. Jack Henningfield, Ph.D., vice president of Research, Health Policy, and Abuse Liability at PinneyAssociates, concluding that there is "insufficient evidence" for the U.S. Drug Enforcement Administration (DEA) to ban or otherwise restrict kratom under the Controlled Substances Act.  According to the comprehensive Henningfield analysis, kratom's potential for abuse and dependence is as low or lower than such widely used and unscheduled substances as "nutmeg, hops, St. John's Wort, chamomile, guarana, and kola nut."  
  • Conducted in November 2016 an online survey of 105 emergency room (ER)/trauma health care professionals that found zero reported cases of deaths related to kratom. The new poll of America's front-line medical professionals also uncovered precisely zero percent support among those surveyed for a DEA ban on the coffee-like herb kratom.
  • Encouraged a set of two letters sent on October 1, 2016 by a politically diverse group of 11 Senators, including Sen. Orrin G. Hatch (R-UT), Sen. Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ), calling on the DEA to halt the proposed scheduling and allow for a regular rulemaking process permitting the public, scientific experts, and Congress to provide input. 
  • Facilitated letters to the DEA and the Office of Management and Budget sent on September 2, 2016 by a bipartisan group of 51 U.S. House Members urging a halt to the DEA's push to ban kratom.
  • Worked with the Pain News Network on a September 2016 survey of 6150 kratom users about their experience with the herb.
  • Promoted a successful and widely publicized September 13, 2016 "March for Kratom" in September at the White House.
  • Circulated  a "We The People" petition targeting the White House that accumulated more than 142,000 signatures.

ABOUT AKA
 
The America Kratom Association, a consumer-based non-profit organization, is here to set the record straight, giving a voice to those suffering and protecting our rights to possess and consume kratom. AKA represents tens of thousands of Americans, each of whom have a unique story to tell about the virtues of kratom and its positive effects on their lives. www.americankratom.org

SOURCE American Kratom Association

Related Links

http://www.americankratom.org

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.